Reditrex - NDC Database

16 records found

Page:1

66220-807 Jul 01, 2020
Reditrex 7.5 mg/.3ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

66220-810 Jul 01, 2020
Reditrex 10 mg/.4ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

66220-812 Jul 01, 2020
Reditrex 12.5 mg/.5ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

66220-815 Jul 01, 2020
Reditrex 15 mg/.6ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

66220-817 Jul 01, 2020
Reditrex 17.5 mg/.7ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

66220-820 Jul 01, 2020
Reditrex 20 mg/.8ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

66220-822 Jul 01, 2020
Reditrex 22.5 mg/.9ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

66220-825 Jul 01, 2020
Reditrex 25 mg/ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

69605-807 Jul 01, 2020
Reditrex 7.5 mg/.3ml Subcutaneous Injection, Solution by Cenexi - Bla

69605-810 Jul 01, 2020
Reditrex 10 mg/.4ml Subcutaneous Injection, Solution by Cenexi - Bla

69605-812 Jul 01, 2020
Reditrex 12.5 mg/.5ml Subcutaneous Injection, Solution by Cenexi - Bla

69605-815 Jul 01, 2020
Reditrex 15 mg/.6ml Subcutaneous Injection, Solution by Cenexi - Bla

69605-817 Jul 01, 2020
Reditrex 17.5 mg/.7ml Subcutaneous Injection, Solution by Cenexi - Bla

69605-820 Jul 01, 2020
Reditrex 20 mg/.8ml Subcutaneous Injection, Solution by Cenexi - Bla

69605-822 Jul 01, 2020
Reditrex 22.5 mg/.9ml Subcutaneous Injection, Solution by Cenexi - Bla

69605-825 Jul 01, 2020
Reditrex 25 mg/ml Subcutaneous Injection, Solution by Cenexi - Bla

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.